Quoin Pharmaceuticals QNRX Stock
Quoin Pharmaceuticals Price Chart
Quoin Pharmaceuticals QNRX Financial and Trading Overview
| Quoin Pharmaceuticals stock price | 0.74 USD |
| Previous Close | 0.54 USD |
| Open | 0.53 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 1100 |
| Day's Range | 0.52 - 0.54 USD |
| 52 Week Range | 0.42 - 28.11 USD |
| Volume | 90.27K USD |
| Avg. Volume | 221.07K USD |
| Market Cap | 6.4M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 4.8518526E-5 |
| EPS (TTM) | -9.64 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.67 USD |
QNRX Valuation Measures
| Enterprise Value | -6568980 USD |
| Trailing P/E | 4.8518526E-5 |
| Forward P/E | -0.5192308 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.58631927 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.674 |
Trading Information
Quoin Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -87.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 28.11 USD |
| 52 Week Low | 0.42 USD |
| 50-Day Moving Average | 0.48 USD |
| 200-Day Moving Average | 1.43 USD |
QNRX Share Statistics
| Avg. Volume (3 month) | 221.07K USD |
| Avg. Daily Volume (10-Days) | 117.74K USD |
| Shares Outstanding | 11.85M |
| Float | 10.86M |
| Short Ratio | 0.43 |
| % Held by Insiders | 8.29% |
| % Held by Institutions | 0.87% |
| Shares Short | 83.91K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 8:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.73% |
| Return on Equity (ttm) | -202.29% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -9753171 USD |
| Net Income Avi to Common (ttm) | -10367029 USD |
| Diluted EPS (ttm) | 11129.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.99M USD |
| Total Cash Per Share (mrq) | 1.43 USD |
| Total Debt (mrq) | 4.02M USD |
| Total Debt/Equity (mrq) | 36.87 USD |
| Current Ratio (mrq) | 4.177 |
| Book Value Per Share (mrq) | 0.921 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8133709 USD |
| Levered Free Cash Flow (ttm) | -4541377 USD |
Profile of Quoin Pharmaceuticals
| Country | United States |
| State | VA |
| City | Ashburn |
| Address | 42127 Pleasant Forest Court |
| ZIP | 20148-7349 |
| Phone | 703-980-4182 |
| Website | https://quoinpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; a Master Service Agreement with Therapeutics Inc.; and a research agreement with Queensland University of Technology. The company was founded in 2018 and is based in Ashburn, Virginia.
Q&A For Quoin Pharmaceuticals Stock
What is a current QNRX stock price?
Quoin Pharmaceuticals QNRX stock price today per share is 0.74 USD.
How to purchase Quoin Pharmaceuticals stock?
You can buy QNRX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Quoin Pharmaceuticals?
The stock symbol or ticker of Quoin Pharmaceuticals is QNRX.
Which industry does the Quoin Pharmaceuticals company belong to?
The Quoin Pharmaceuticals industry is Biotechnology.
How many shares does Quoin Pharmaceuticals have in circulation?
The max supply of Quoin Pharmaceuticals shares is 3.69M.
What is Quoin Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Quoin Pharmaceuticals PE Ratio is now.
What was Quoin Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Quoin Pharmaceuticals EPS is -9.64 USD over the trailing 12 months.
Which sector does the Quoin Pharmaceuticals company belong to?
The Quoin Pharmaceuticals sector is Healthcare.
Quoin Pharmaceuticals QNRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}